Mutflash - Medizinische Argumentationen und Studiensammlungen
1.25K subscribers
11.3K photos
1.89K videos
255 files
10.8K links
Unser Hauptkanal:

https://t.me/Mutflash

P.s.: Leute die ohne eine vernünftige Grundlagenargumentation gegen Biom/ Virom argumentieren sind UNwillkommen!
Download Telegram
We have checked and there is little to no spike protein found in the plasma, and I think the high AB production comes from failure of apoptotic pathways that cause neutrophils to remain in circulation after exposure to spike protein, this leads to sustained immune activation, and subsequent high AB levels as response.

https://x.com/kevinmccairnphd/status/2081869210809217062?s=52&t=fHNy04S5p-78vK_ah9g3hw

Witzig! McCairn räumt es selbst ein, aber schlussfolgert natürlich völlig Banane und wirres Zeugs.

Reminder:

"Because PEG triggers initial IgM release by directly crosslinking B-cell receptors in the spleen81, IgM can be measured ex vivo even in the absence of intact splenic architecture82. We observed that blocking inflammatory signaling with either TAK-242 or 20H2 increased anti-PEG IgM production increased for splenocytes treated with 304 LNPs in the presence of 20H2 (Fig. 6H). Next, to confirm that a similar phenomenon occurs in vivo, we injected mice with 304Oi10 and 306Oi10 LNPs along with CD1d and TLR4 inhibitors and corresponding isotype and solvent controls. Indeed, CD1d and TLR4 blockade caused a significant increase in PEG-IgM (Fig. 6I, S15A) and PEG-IgG antibodies (Fig. 6J, S15B). "

Chaudhary N, Kasiewicz LN, Newby AN, Arral ML, Yerneni SS, Melamed JR, LoPresti ST, Fein KC, Strelkova Petersen DM, Kumar S, Purwar R, Whitehead KA. Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d. Nat Biomed Eng. 2024 Nov;8(11):1483-1498. doi: 10.1038/s41551-024-01256-w. Epub 2024 Oct 3. PMID: 39363106; PMCID: PMC11863198.

"These vaccines utilize four-component lipid nanoparticles (LNPs) that have been shown to potently induce IL-1, IL-6 secretion, TFH and GC B cell generation in humans1,10,36,37,38. "

Connors, J., Joyner, D., Mege, N.J. et al. Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals. Commun Biol 6, 188 (2023). doi: 10.1038/s42003-023-04555-1

Nguyen H, Alexander K, Collinge M, et al., mRNA-LNPs induce immune activation and cytokine release in human whole blood assays across diverse health conditions Molecular Therapy, DOI: 10.1016/j.ymthe.2024.12.019; 33, 2872-2885

Qin Z, Bouteau A, Herbst C, Igyártó BZ. Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion. bioRxiv [Preprint]. 2022 Aug 20:2022.03.16.484616. doi: 10.1101/2022.03.16.484616. Update in: PLoS Pathog. 2022 Sep 2;18(9):e1010830. doi: 10.1371/journal.ppat.1010830. PMID: 36032972; PMCID: PMC9413714

Ich mag den hier:

https://x.com/surf4children/status/2081877785442705624

Narf!
😁1
So sieht jemand aus, der nicht damit rechnete, dass er jemals für sein Verhalten belangt werden würde:

Voller Hass auf Paul und völlig fassungslos, dass er nur noch die Berufung auf den 5. Verfassungszusatz als Antwort runterstammeln kann.
Die „Corona-Bekämpfer“ der 3a erhielten Urkunden.

Weil sich die acht bis neunjährigen Kinder mindestens fünf mal „freiwillig“ testen ließen.

#RichtigErinnern

t.me/Rosenbusch
🤬1
Ich bin heute in totaler Arschlochlaune und überlege, ob ich diesem Professor nen echten Seitenhieb via E-Mail verpassen sollte:

"Dear Professor Abd El-Aty,

I hope you are doing well.

Last year, you handled our submission entitled "Lipid Nanoparticles as Active Biointerfaces: From Membrane Interaction to Systemic Dysregulation."
Although the manuscript was not accepted at that time, I would like to thank you for considering our work.

Since then, the manuscript has undergone a thorough peer-review process at another journal. The reviewers provided detailed and constructive comments that helped us further refine the scientific presentation, strengthen the discussion of the evidence, and improve the overall clarity of the manuscript. We are pleased to share that the revised manuscript has now been accepted for publication in Acta Pharmaceutica Sinica B:

Seger, F., Gutschi, L.M., Seneff, S. (2026). Lipid Nanoparticles as Active Biointerfaces: From Membrane Interaction to Systemic Dysregulation. Acta Pharmaceutica Sinica B.
https://doi.org/10.1016/j.apsb.2026.07.001

Looking back, I particularly valued the experience of a peer-review process that engaged deeply with the scientific content of the manuscript and contributed substantially to its improvement.

With best regards,

Falko Seger"

(Den Screenshot würde ich als JPG noch anhängen. XD)
😁4
Retrospektiv betrachtet, haben wir zwischen 2,500 - 10,000 USD gespart und nen fast 4fachen Impactfactor abgestaubt im 5 Jahresschnitt. Und wir vermieden ein Journal, das eindeutig gegen COPE-Richtlinien verstößt und bekamen als Sahnebonbon großartige Reviewer, die das Potenzial sahen und begriffen, wovon wir schreiben.
👏6❤2